Medical devices company Zimmer Biomet Holdings Inc. said adjustments to transfer pricing are among early steps the company is taking to mitigate tariff impacts.
The company expects between $60 million and $80 million in tariff impacts in 2025, company CFO Suketu Upadhyay said on an earnings call Monday—although, he added, “you could expect it to be higher” in 2026.
Asked by analysts why the 2025 impact isn’t expected to be larger, he said the bulk of the company’s production and manufacturing is already in the US.
“So that overall lowers our exposure some bit, but we have already taken ...
Learn more about Bloomberg Tax or Log In to keep reading:
See Breaking News in Context
From research to software to news, find what you need to stay ahead.
Already a subscriber?
Log in to keep reading or access research tools and resources.